Tandem Diabetes Agrees to Pay Roche $36M in Patent Infringement Deal

Dow Jones
2025/05/24
 

By Katherine Hamilton

 

Tandem Diabetes Care has agreed to pay Roche Holding $36 million to settle a patent infringement claim.

The two companies have granted each other licenses to patents on the insulin delivery systems in question for the next 10 years, Tandem said Friday.

Swiss pharmaceutical company Roche filed an action in December 2023 alleging one of Tandem's insulin pumps infringed upon its patent. Roche was seeking monetary damages and for Tandem to stop selling the t:slim X2 pump.

San Diego-based Tandem will make an initial payment of $8 million under the agreement, and pay out the remaining balance in equal installments over the next four years.

 

Write to Katherine Hamilton at katherine.hamilton@wsj.com

 

(END) Dow Jones Newswires

May 23, 2025 17:08 ET (21:08 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10